
MHIP aims to preserve and enhancepurchasingpower amid rising medical costs through proprietary actuarial data and quantitative modeling. The fundanalysis relies on Mis extensive dataset of real healthcare claims, covering approximately 35 million insured individuals, to project healthcare inflation based on trends in medical and pharmacy costs.Investments consist ofequities and fixed income securities across the healthcare supply chain, along with inflation-hedging instruments such as commodities, TIPS, andTreasury bonds.Typically, MHIP isrebalanced monthly using a quantitative model toreflect changes in US healthcare cost inflation. The strategy increases exposure to equities and commodities during periods of higher inflation and shifts towarddebtwhen inflation is lower.Holdings may also include derivatives such as swaps, options, and futures, as well as ETFs.
Sector exposure data isn't available for this fund yet.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| — | United States Treasury Bill 07/21/2026 | 25.76% | $257.66K |
| XFIV | BondBloxx Bloomberg Five Year Target Duration US Treasury ETF | 11.46% | $114.63K |
| SPLG | State Street SPDR Portfolio S&P 500 ETF | 8.68% | $86.83K |
| XHLF | BondBloxx Bloomberg Six Month Target Duration US Treasury ETF | 4.51% | $45.11K |
| LLY | Eli Lilly & Co | 4.43% | $44.28K |
| UNH | UnitedHealth Group Inc | 3.78% | $37.78K |
| JNJ | Johnson & Johnson | 2.69% | $26.89K |
| TMO | Thermo Fisher Scientific Inc | 2.63% | $26.33K |
| ABT | Abbott Laboratories | 2.22% | $22.16K |
| — | GLD 08/19/2026 349.57 C | 2.15% | $21.51K |
| ISRG | Intuitive Surgical Inc | 2.03% | $20.30K |
| DHR | Danaher Corp | 1.89% | $18.89K |
| SYK | Stryker Corp | 1.75% | $17.47K |
| MRK | Merck & Co Inc | 1.57% | $15.65K |
| MDT | Medtronic PLC | 1.44% | $14.41K |
| CVS | CVS Health Corp | 1.28% | $12.84K |
| ABBV | AbbVie Inc | 1.12% | $11.19K |
| BSX | Boston Scientific Corp | 0.93% | $9.35K |
| HCA | HCA Healthcare Inc | 0.90% | $9.02K |
| MCK | McKesson Corp | 0.90% | $8.97K |
| BMY | Bristol-Myers Squibb Co | 0.85% | $8.55K |
| ELV | ELEVANCE HEALTH INC | 0.85% | $8.54K |
| CI | Cigna Group/The | 0.75% | $7.53K |
| EW | Edwards Lifesciences Corp | 0.72% | $7.20K |
| BDX | Becton Dickinson & Co | 0.61% | $6.05K |